Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-25 @ 4:57 PM
NCT ID:
NCT02609503
Group ID:
EG000
Title:
Pembrolizumab Concomitant With and Post 7 Weeks of Radiation
Description:
All patients will receive Intensity Modulated Radiotherapy Treatments (IMRT) as per standard of care. The total dose will be 70 Gray(Gy) at 2Gy/fraction, 35 fractions, Monday to Friday, for 7 weeks.
Starting on the first day of radiotherapy, patients will be treated with pembrolizumab 200 milligrams (mg) intravenous (IV) every 3 weeks for 6 doses.
Deaths Number Affected:
7
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
29
Other Number Affected:
29
Other Number At Risk:
29
Study:
NCT02609503
Results Section:
NCT02609503
Adverse Events Module:
NCT02609503